58.
EPILEPSY
Maryam Jowza and Dominika James
INTRODUCTION
Scizures are often related to other underlying conditions,
such as trauma, tumor, or metabolic abnormality, with
10% risk of lifetime occurrence. In comparison, epi
lepsy is a congenital condition affecting approximately 196
of the population and involving recurrent seizure disorder.
Epilepsy is mose common at extremes of age and in those
with structural brain abnormalities. Seizures can be classi-
fied as “focal” if the seizure arises from one hemisphere or
“generalized” if the seizure arises from both hemispheres.
Scizuresare considered as “simple” when no lossofconscious-
ness is involved and “complex” with loss of consciousness.
Seizures can arise as a result of dysfunctional parox-
ysmal neuronal discharge resulting from dysregulation of
neuronal circuits and imbalance between excitatory and in-
hibitory central nervous system (CNS) modulatory centers
Although the precise mechanism leading to seizures is
not known, seizures can be congenital, caused by struc
tural CNS abnormality (tumor, scar), or associated with
transient metabolic dysregulation, such as hypoglyeemia,
hyponatremia, medication toxicity or withdrawal (with-
drawal of medications that inhibit neuronal transmission,
eg» as benzodiazepines or antiepileptic drugs [AEDs] may
lead to unopposed neuronal excitation, leading to seizure).
THERAPEUTIC OPTIONS
As epilepsy is thought to be due to an imbalance between
excitatory and inhibitory neuronal activity, AEDs act by
either increasing inhibitor neurotransmiteer activity (y
aminobutyric acid [GABA]), decreasing excitatory neu-
rotransmitter activity (glutamate, aspartate) or reducing
inward voltage-gated positive currents (sodium channels,
calcium channels). Partial seizures are treated with carba-
mazepine, valproate, or phenytoin, For generalized seinures,
‘medications such as barbieurates, gabapentin, or lamotrigine
reused Phenytoin, barbiturates, and carbamazepine cause
hepatic enzyme induction. AEDs are also associated with
dose-dependent toxicity. Phenytoin may cause intraoperative
hypotension and dysthythmias, and valproate is associated.
with liver toxicity and increased bleeding)
Surgical options for treatment of refractory epilepsy in
clude left vagal nerve stimulator implantation (right vagus
nerve is not recommended due to significane cardiac inner
vation) or seizure site surgical resection (most often em:
poral lobectomy)
“The most favorite candidates for surgical resection are
patients wich complex partial seizures, unilateral temporal
lobe focus, normal intelligence quotient, motivation, no
diffuse brain damage, seizures that were uncontrolled by
medications, and a seizure focus that is resectable without
causing major neurologic damage.
Scatus epilepticus is defined as 30 minutes or more of
continuous seizure activity without complete recovery or
with incomplete recovery of consciousness.® This is a med-
ical emergency as it can lead to cerebral damage and can be
faral. In the event of status epilepticus, one should secure
the airway, ventilate the patient with oxygen, and monitor
and support the cardiovascular function with establish-
‘ment of intravascular access and administration of seizure-
suppressing medications. Intubation should be performed
usinga short-acting muscle relaxant, suchas uccinylcholine
oor mivacurium, as continuous monitoringof tonic activity is
essential for evaluating the efficacy of treatment. Use of thi
opental or propofol is preferred over other sedatives due to
their transient seizure-suppressing effects, Benzodiazepines
remain the firstline therapy for status epilepticus, followed
by fosphenytoin, levetiracetam, or valproate if the seizure
is not resolved. Alternatively, use of intravenous phenobar-
bital may be considered.
ANESTHETIC CONSIDERATIONS.
Many ofthe antiepileptic medications tend to alter the phar
rmacokineties and pharmacodynamics of anesthetic drugs
by enzyme function alterations, such as enzyme induction
or inhibition (Table 58.1) In turn, some anesthetic agents
are known to affect the seizure threshold and may induce
an intraoperative epileptic event. As such, these interactions
154 + CENTRAL NERVOUS SYSTEMTable $8.1 SUMMARY OF COMMONLY USED AEDS, SIDE EFFECTS, AND ANESTHETIC CONSIDERATIONS,
CONSIDERATIONS,
Phenytoin Gingival hyperplasia Dysthythmias Induction Accelerated metabolism ofbenzodiazepines,
Hiesutiom Hypotension CyP3A4 ‘buprenorphine, meperidine, methadone,
Aplastic anemia duction and feneanyl
CYP2CI9. Resistance to NMBDs
Accelerated metabolism of diszepam
Fosphenytoin etter No clfcet
side-effect profile
than phenytoin)
‘Valptoic acid Hepatic failure Increased surgical bleeding Induction Resistance o NMBDs
Pancreat “Thrombocytopenia CYP2CI9 Accelerated metabolism of diazepam
D.C Inhibition Decreased methadone elimination
cyP2p6
Carbamazepine __Diplopia Revitanceto NMBDs Induction _ Accelerated metabolism of benzodiazepines,
Ageanulocytosis ‘Hyponatremia cypsas buprenorphine, meperidine, methadone,
sis Induction snd fentanyl
D.C.S CYP2CI9 Resistance to NMBDs
Accelerated metaholism of diazepam
Oxycarbazepine Hypersensitivity, rash Hyponatremia
D.C,
Phenobarbital Withdrawalsyndrome/ Hypotension (venous Induction Accelerated metabolism ofbenzodiazepines,
addiction ppoolingand negative CYP3A4 ‘buprenorphine, meperidine, methadone,
D.C.S fonotropic effets) Induction and fentanyl
NS depression CYP2B6 Enhanced methadone metabolism
Lamotrigine SIS, diplopia No lfect
Insomnia, D, C,S
‘Topiramate ‘Weight loss, Renally excreted 65% No effect.
nephrolithias Metabolic acidosis
DCS
Gabapentin ‘Weight gain,D,C,S —Renally excreted 100% Noeffect
Tevetiracetam D.CS Renallyexcreted 100% No effect
‘Cyconfasion:D, deanes Sedan: 9S
sJohasonsydvom
must be taken into consideration when establishing the an-
esthetie plan.
ANESTHETIC CONSIDERATION
PREOPERATIVE,
It is important to determine preoperatively if the patient
hasa known diagnosis of epilepsy orf they are experiencing,
new onset seizures. Those with a new onset of symptoms te
{quirean evaluation to determine the etiology of the seizures.
As seizures can be caused by a variety of issues, including
trauma, medication toxicity or withdrawal, fevers, tumors,
‘or metabolic abnormalities, it is best thar the presence of
such conditions be determined prior to an anesthetic.’ In
the review of medical history its also important to deter
mine the degree of control of seizures, triggers (fasting sleep
15 MAC in epileptic patients and inthe
presence ofhypocapnia
[NMBD,neuromutslar blocking drag: MAC, minimal sola concentration.
ape fom Baja J Jindal R.Fplepeyandnoneplepey sarge Recent avancemensin anesthesia management. dnt Exe
ee 201370) 10-17 4:10 4103/0059-162.1139|
commonly used AEDS, their side effects and interactions
with anesthetics, and their effect on enzymes,
Some anestherie agents can have proconvulsant
properties. For example, methohexital, alfentanil, and
remifentanil can lower the seizure threshold, Agents such
as benzodiazepines, propofol, and thiopental lower the
seizure threshold, Table 58,2 summarizes medications
and their known effeets on seizures
In order to avoid reduction of the seizure threshold
intraoperatively, hypoxia, hypotension, hypocapnia, and
hyponatremia should be avoided. Regional anesthesia can
bbe employed safely in an epileptic patient.*®
POSTOPERATIVE
Patients should resume AED treatment as soon as pos-
sible postoperatively. If multiple doses may be missed,
medications should be administered using either the oral
route if possible or the intravenous route. Phenytoin, so-
dium valproate, and levetiracetam are available in intra
venous form with oral and intravenous doses equivalent.’
Patients with preexisting poorly concrolled epilepsy are at
highest risk for a seizure in the postoperative period and
will require special attention and timely administration
of AEDs,
156 + CENTRAL NERVOUS SYSTEMREFERENCES.
1, GlauserT, tal. Evidence based guideline treatment of convulsive
os epilepsics in and adults repore of the Guideline
wmmitee of the American Epilepey Sociry. Fpilepiy Carn
2016 16(1):48-61
2. Maranhio MY, et al. Eplepay and anesthesia. Rev Bras Anestesiol.
2011;61(2)232-236
3. Bajora SJ, Jindal R. Epilepsy and nonepilepsy surgery: recent
sdvancements in anesthesia management, cnet Lisayt Ret.
2013:70}:10-17
4, Perks A, etal. Anaesthesia an
562-571,
Kofke WA. Anesthesic management of che paient with
"Border Closure Only Increased Precariousness": A Qualitative Analysis of The Effects of Restrictive Measures During The COVID 19 Pandemic On Venezuelan's Health and Human Rights in South America